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Abstract: Four new alkaloids, sinensines B–E (1–4), together with one known alkaloid, sinensine (5), were isolated from the fruit-
ing bodies of Ganoderma sinense. Their structures were elucidated on the basis of 1D and 2D NMR spectra analysis. The structure 
of sinensine E was confirmed by X-ray crystallographic analysis of its acetyl product (4a). 
Keywords: Ganoderma sinense, Ganodermataceae, alkaloids, sinensines
Introduction 
The fruiting bodies of Ganoderma spp., commonly known 
as the Reishi mushroom, were widely used in China, Japan, 
and Korea as valuable crude drug, especially in the treatment 
of chronic hepatitis, nephritis, hepatopathy, neurasthenia, 
arthritis, bronchitis, asthma, gastric ulcer, and insomnia.1 The 
chemical constituents of Ganoderma spp. comprised poly-
saccharides, fatty acids, alkaloids, nucleotides, proteins and 
peptides, trace elements, sterols, and triterpenoids.2–4 Among 
them, triterpenoids were mainly responsible for the biological 
activities. It was reported that triterpenoids played an 
important role in antitumor,5 inhibiting HIV-1 protease,6 
antiplasmodial,7 antiviral,8 and antimicrobial.9 
Alkaloids were another chemical constituents obtained from 
Ganoderma spp. In 1990, ganoderma alkaloids A and B were 
isolated from the fruiting bodies of G. capense for the first 
time.10 Researchers had detected ganoderma alkaloid by means 
of HPLC, but they did not find the trace of ganoderma 
alkaloid.11 Until 2010, from the fruiting bodies of G. sinense, a 
novel alkaloid, named sinensine was isolated and exhibited 
activity in protecting the injury induced by hydrogen peroxide 
oxidation on HUVEC.12 
To discover ganoderma alkaloids and evaluate their biologi-
cal activities, amounts of the fruiting bodies of G. sinense 
conducted. On our progress of investigating the chemical con-
stituents of G. sinense, three new triterpenoids with four-
member ring displaying anti-tumor activity had been report-
ed.13 In this paper, the isolation and identification of four new 
alkaloids, sinensines BE (14), together with one known 
alkaloid, sinensine (5) were reported. Their structures were 
identified mainly by 1D, 2D NMR spectra and X-ray analysis. 
 
Results and Discussion 
The fruiting bodies of G. sinense (50 kg) were extracted 
with 95% ethanol and filtered, concentrated in vaccum and 
partitioned with petroleum, ethyl acetate (EtOAc) and n-
butanol, respectively. The EtOAc extract (1.5 kg) was repeat-
edly chromatographed on silica gel, RP-18, Sephadex LH-20, 
and HPLC to yield sinensines BE (14) and sinensine (5). 
The molecular formula of compound 1 was assigned as 
C14H13NO2 ([M + H]+; m/z 228.1003) by HRESIMS, which 
established nine degrees of unsaturation. The IR spectrum 
showed hydroxyl group (3383 cm−1) and aromatic rings (1464 
cm−1). The 1H NMR spectrum (Table 1) of 1 exhibited signals 
at δH 7.89 (d, 1H, J = 2.4 Hz), 7.27 (2H, m), 8.21 (s, 1H), and 
7.84 (s, 1H). The 13C NMR spectrum (Table 1) showed four-
teen carbon signals, including three methylene siganls at δC 
32.9, 30.0 and 25.0; five sp2 methine signals at δC 141.8, 119.6, 
119.3, 115.9 and 113.5; six sp2 quaternary-carbon signals at δC 
156.2, 156.1, 153.6, 151.1, 138.5 and 120.4. These data of 1 
were similar to those of sinensine (5)12. However, the 1D spec-
tra of 1 displayed one more sp3 methylene and sp2 methine, as 
well as less a methyl and an oxymethine than those of 5. 
In 1H NMR spectrum, the signals at δH 8.21 (s, 1H) and 7.84 
(s, 1H) belonging to pyridine indicated that two olefinic car-
bons were located at C-3 and C-7. So, the location of cyclo-
pentenyl group in 1 was different with that of in 5. The HMBC 
correlations from H-7 (δH 8.21) to C-2 (δC 156.2) and C-9 (δC 
138.5), from H-3 (δH 7.84) to C-1' (δC 120.4), C-9 (δC 138.5) 
and C-8 (δC 156.1), from H-4 (δH 2.67) to C-9 (δC 138.5), C-8 
(δC 156.1) and C-3 (δC 115.9), from H-6 (δH 2.64) to C-7 (δC 
141.8), C-9 (δC 138.5) and C-8 (δC 156.1), and from H-5 (δH 
1.78) to C-9 (δC 138.5), C-8 (δC 156.1), C-4 (δC 32.9), and C-6 
(δC 30.0) confirmed that the cyclopentenyl group was cyclized 
with pyridine at C-8 and C-9. 
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A dihydroxyl phenyl group at C-2 was deduced by the 
HMBC correlations from H-2' (δH 7.27) to C-1' (δC 120.4) and 
C-3' (δC 153.6), and from H-3 (δH 7.84) to C-1', C-9 and C-8. 
The locations of two hydroxyl group at C-3' and C-5' were 
assigned by the 1H NMR spectrum and the coupling constants 
of protons. H-2', H-4' and H-6' with coupling constants of no 
more than 3.0 Hz indicated that they were at meta-positions. 
Thus, sinensine B (1) was established. 
Sinensine C (2) possessed a molecular formula C14H13NO3 
by HRESIMS ([M + H]+; m/z 244.0966, calcd 244.0973), 
which differed from 1 for one more oxygen atom. By detail 
comparison of 1D NMR data of 2 and 1, they were similar, 
except for the absence of a methylene and the presence of an 
oxymethine. Above data indicated that an additional hydroxyl 
group in 2 was attached to cyclopentenyl group. The further 
proof was established from the HMBC correlations from H-4 
(δH 2.93 and 2.66) to C-9 (δC 141.5), C-8 (δC 157.2) and C-3 
(δC 116.3), from H-5 (δH 2.42 and 2.13) to C-9, C-8, C-4 (δC 
30.4), and C-6 (δC 73.7), and from H-6 (δH 5.48) to C-7 (δC 
142.8), C-9 and C-8. This illustrated that the hydroxyl group 
was located at C-6. Thus, the plantar structure of compound 2 
was identified. 
Molecular formula C14H11NO3 of compound 3 was deter-
mined by HRESIMS. Its IR spectrum showed presence of hy-
droxyl group (3445 cm−1) and aromatic rings (1614 and 1482 
cm−1). On comparison of the 1D NMR data between 3 and 2, 
the signals due to the phenyl group and the group of cyclopen-
ta[b]pyridine could be observed. However, the 1D NMR spec-
tra of 3 showed a down-field sp2 quaternary carbon signal (δC 
160.8) instead of an up-field sp2 methine signal in 2, which 
suggested that an sp2 methine in 2 was oxidized to an sp2 qua-
ternary carbon in 3.  
In the 1H-1H COSY spectrum, cross peak between signals at 
8.56 (d, J = 2.0 Hz) and 7.35 (2H, overlapped) indicated that 
these signals belonged to the phenyl group. This deduction 
would be confirmed by the HMBC correlations from H-3' (δH 
7.35), H-4' (δH 7.35) and H-6' (δH 8.56) to C-2' (δC 155.8), C-5' 
(δC 146.5), and C-1' (δC 123.1). Meanwhile, analysis of their 
coupling constants suggested that the phenyl group was an 
ABC system, which demonstrated that 3 had a 1',2',5'-
trisubstituted phenyl group. 
Since there were two oxidized olefinic carbons at the phenyl 
group, the additional oxidized olefinic carbon could be located 
at the pyridine. Meanwhile, in the HMBC spectrum, the corre-
lations of H-7 with C-8, C-9 and C-6 indicated that the addi-
tional oxidized olefinic carbon was at C-3. Base on the molec-
ular formula C14H11NO3 (10 degree of unsaturation) of 3, we 
deduced that C-2' and C-3 formed an ether bond. Furthermore, 
ChemDraw 3D model of 3 (Figure 1) showed that the phenyl 
group, the furan and the pyridine were formed a conjugate 
Table 1. 1H (500 MHz, C5D5N, J in Hz) and 13C NMR (125 MHz, C5D5N) data for compounds 1–4. 
 
No. 
sinensine B (1) sinensine C (2) sinensine D (3) sinensine E (4) 
δH δC, type δH δC, type δH δC, type δH δC, type 
2  156.2, C  155.4, C  115.1, C   154.1, C 




2.67, overlapped 32.9, CH2 2.93, ddd  
(16.7, 8.5, 4.4) 
2.66, m 
30.4, CH2 3.74, ddd  
(18.7, 8.8, 4.3) 
3.35, td (18.7, 7.8) 
31.9, CH2 2.80, ddd  





1.78, m 25.0, CH2 2.42, m 
2.13, m 
36.3, CH2 2.53, m 
2.24, m 
36.1, CH2 2.43, m 
2.15, m 
36.3, CH2 
6 2.64, overlapped 30.0, CH2 5.48, br. s 73.7, CH 5.57, t (6.4) 73.7, CH 5.51, t (6.0) 73.9, CH 
7 8.21, s 141.8, CH 8.68, s 142.8, CH 9.19, s 151.8, CH 8.91, s 145.8, CH 
8  156.1, C  157.2, C  157.4, C  148.4, C 
9  138.5, C  141.5, C  144.4, C  142.7, C 
10       5.20, d (2.6) 65.7, CH2 
1'  120.4, C  120.4, C  123.1, C  125.1, C 
2' 7.27, overlapped 119.6, CH 7.27, overlapped 119.9, CH  155.8, C  150.0, C 
3'  153.6, C  153.6, C 7.35, overlapped 120.7, CH 7.12, d (8.6) 118.9, CH 
4' 7.89, d (2.4) 113.5, CH 7.89, s 113.6, CH 7.35, overlapped 118.2, CH 7.22, m 118.3, CH 
5'  151.1, C  151.2, C  146.5, C  147.8, C 
6' 7.27, overlapped 119.3, CH 7.27, overlapped 119.4, CH 8.56, d (2.0) 110.5, CH 8.44, d (2.6) 111.8, CH 
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surface. The conjugate surface could result in the carbon sig-
nal of C-2 upfield shift to 115.1 ppm. However, ChemDraw 
3D figures of 2 and 4 did not display the conjugate surface, so 
the chemical shifts of C-2 in 2 and 4 were about 155 ppm. 
Finally, the structure of 3 was deduced. 
The molecular formula of 4 was established as C15H13NO3 
by the HRESIMS. The 1H and 13C NMR spectra of 4 revealed 
the siganls at δH 8.44 (d, 1H, J = 2.6 Hz), 7.12 (d, 1H, J = 8.6 
Hz) and 7.22 (m, 1H), and siganls at δC 150.0, 147.8, 125.1, 
118.9, 118.3 and 111.8 due to the 1',2',5'-trisubstituted phenyl 
group. Carefully compared the 1D NMR between 3 and 4, an 
oxymethylene signal (δH 5.20 and δC 65.7) in 4 was observed 
and a downfield carbon signal at 160.8 ppm in 3 was instead of 
a upfield carbon signal in 4, which suggested that the ox-
ymethylene of 4 was instead of the hydroxyl group of 3 at C-3. 
Above deduction and the presence of an ether bond between 
C-2' and C-10 were confirmed by the HMBC correlations from 
H-10 (δ 5.20) to C-3 (δ 123.5), C-2' (δ 150.0) and C-8 (δ 
148.4). 
In order to further verify the structure of 4 deduced above 
and to describe the configuration of 4, the single-crystal X-ray 
would be helpful. However, 4 was not easy to crystallize in 
most kinds of organic solvent. Fortunately, acetylization of 4 
afforded 5',6-diacetyl sinensine E (4a) crystallized in 
MeOH/H2O solvent. Consequently, a single X-ray crystallo-
graphic diffraction14 of 4a was conducted as shown in Figure 2. 
The relative configuration of OH-6 was deduced as β-oriented. 
Based on above evidence, the structure of 4 was assigned. 
On the basis of the specific rotations of 2, 3 and 4, it was il-
lustrated that the relative configurations of OH-6 in 2 and 3 
were determined to be β, the same as that of 4. 
 
Experimental Section 
General Experimental Procedures. Petroleum ether (PE) 
for chromatography had a b.p. range of 60–90°. Column 
chromatography (CC): silica gel (SiO2, 200–300 mesh; Qing-
dao Marine Chemical, Inc.); Lichroprep RP-18 (40–63 μm; 
Merck), or Sephadex LH-20 (Pharmacia). Optical rotations: 
Jasco P-1020 spectropolarimeter. IR spectra: Bruker Tensor 27 
instrument, KBr pellets. NMR Spectra: Bruker AV-400 and 
DRX-500 instruments. HRESIMS: API Qstar Pulsar i spec-
trometer; in m/z. 
 
Plant Material. The fruiting bodies of G. sinense were pur-
chased from Yunnan Nanhua wild mushroom market, and 
were identified by Professor Pei-Gui Liu, who was mushroom 
taxonomist in Kunming Institute of Botany, Chinese Academy 
of Sciences. 
 
Extraction and Isolation. The dry fungus (50 kg) was 
ground and extracted in EtOH at 70 ℃ for three times. The 
extract was then decanted and evaporated, and the residue was 
extracted with EtOAc. The EtOAc extract was fractionated by 
CC (silica gel; CHCl3/MeOH step gradients): Fractions 1–4 
(CHCl3/MeOH : 100:1, 50:1, 20:1, 5:1). Fraction 3 
(CHCl3/MeOH : 20:1) was subjected to reverse-phase silica 
gel (MeOH/H2O step gradients: 45%  80%). 60% fraction 
was treated by CC (silica gel; Sepadex LH-20; reverse-phase 
HPLC and prep. TLC) and finally gave 1 (18 mg), 2 (19 mg), 
3 (45 mg), 4 (35 mg) and 5 (15 mg). 
 
Sinensine B (1): white powder (CHCl3/MeOH); [α]25D − 8.18 
(c 0.1, CHCl3/MeOH); UV (MeOH/CHCl3, λmax (log ε)): 266 
(4.20), 345 (2.98) nm; IR (KBr) vmax 3383, 2965, 2930, 2851, 
1464 cm−1; 1H and 13C NMR: see Table 1; ESIMS m/z 228 [M 
+ H]+; positive ion HRESIMS m/z 228.1003 [M + H]+ (calcd. 
for C14H14NO2, 228.1024). 
 
Sinensine C (2): white powder (CHCl3/MeOH); [α] 25D  − 
11.08 (c 0.1, CHCl3/MeOH); UV (MeOH/CHCl3, λmax (log ε)): 
268 (4.33), 333 (3.01) nm. IR (KBr) vmax 3445, 2978, 1614, 
1482, 1444 cm−1; 1H and 13C NMR: see Table 1; ESIMS m/z 
244 [M + H]+; positive ion HRESIMS m/z 244.0966 [M + H]+ 
(calcd. for C14H14NO3, 244.0973). 
 
Sinensine D (3): yellow powder (CHCl3/MeOH); [α]25D  − 
11.08 (c 0.1, CHCl3/ MeOH); UV (MeOH/CHCl3, λmax (log ε)): 
266 (4.28), 341 (3.12) nm; IR (KBr) vmax 3445, 2978, 1614, 
1482, 1444 cm−1; 1H and 13C NMR: see Table 1; ESIMS m/z 
264 [M + Na]+; positive ion HRESIMS m/z 264.2314 [M + 
Na]+ (calcd. for C14H11NO3Na, 264.2318). 
 
Sinensine E (4): yellow powder (CHCl3/MeOH); [α]25D  − 
7.00 (c 0.1, CHCl3/MeOH); UV (MeOH/CHCl3, λmax (log ε)): 
 
Figure 2.  Single-crystal X-ray structure of 4a. 
2 3
4  
Figure 1.  The ChemDraw 3D figures of 2–4. 
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265 (4.17), 344 (3.20) nm. IR (KBr) vmax 3416, 3267, 1611, 
1575, 1470, 1428 cm−1; 1H and 13C NMR: see Table 1; ESIMS 
m/z 256 [M + H]+; positive ion HRESIMS m/z 256.0974 [M + 
H]+ (calcd. for C15H14NO3, 256.0973). 
 




Crystal Data for 4a: C19H17NO5; M = 339.34, colorless 
piece, space group P21212, a = 11.8937 (3) Å, b = 28.7658 (6) 
Å，c = 5.86480 (10) Å, α =  = γ = 90, V = 2006.53 (7) Å3, Z 
= 4, d = 1.446 mg/cm3, crystal dimensions 0.68 × 0.63 × 0.14 
mm was used for measurements on a Bruker APEX DUO dif-
fractometer with a graphite monochromator (Ф/ω scans, 2θmax 
= 60.08°), Mo Kα radiation. The total number of independent 
reflections measured was 16187, of which 4180 were observed 
(|F|2 ≥ 2 |F|2). Final indices: R1 = 0.0331, wR2 = 0.0877 (w = 
1/|F|2)，S = 1.074. The crystal structure of 4a was solved by 
direct method SHELXS-97 (Sheldrich, G. M. University of 
Gottingen; Gottingen, Germany, 1997) and the full-maxtrix 
least-squares deposited in the Cambridge Crystallographic 
Data Centre (deposition number: 847702). Copies of these 
data can be obtained free of charge via the Internet at 
www.ccdc.cam.ac.uk/conts/retrieving.html (or from the Cam-
bridge Crystallographic Data Center, 12 Union Road, Cam-
bridge CB2 1EZ, U.K.; fax (+44) 1223-336-033; or e-mail: 
deposit @ccdc.cam.ac.uk). 
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